Literature DB >> 12900112

The treatment of wartime brain wounds: traditional versus minimal debridement.

Michael E Carey1.   

Abstract

BACKGROUND: Since World War II, surgeons in Western armies dealing with brain wounds have generally advocated thorough missile track debridement, and many have urged meticulous dural closure to prevent cerebral spinal fluid (CSF) leakage and subsequent infection. For the last decade some reports have appeared wherein wartime brain wounds have been treated by minimal brain debridement with little or no attention to tight dural closure. This report compares and contrasts postdebridement complications reported with each method.
METHODS: I reviewed the pertinent neurosurgical papers from Vietnam, the Israeli war in Lebanon, and the Iran-Iraq war and compared the results of traditional debridement and water-tight dural closure to those following minimal debridement without close attention to dural closure.
RESULTS: Minimal brain debridements without tight dural closure were up to 20 to 30 times more likely to require additional debridement, had a 10-15 times higher incidence of life-threatening CSF leakage, a fivefold increase in postdebridement meningitis, and a 2.5 times greater risk of fatal meningitis.
CONCLUSIONS: Compared to thorough brain debridement and watertight dural closure, minimal debridements and nonwatertight dural closure give inferior results.

Entities:  

Mesh:

Year:  2003        PMID: 12900112     DOI: 10.1016/s0090-3019(03)00352-5

Source DB:  PubMed          Journal:  Surg Neurol        ISSN: 0090-3019


  2 in total

1.  Safe management of paediatric penetrating head injury without a CT scanner: A strategy for humanitarian surgeons based on experience in southern Afghanistan.

Authors:  P Mathew; D M Nott; D Gentleman
Journal:  Ann R Coll Surg Engl       Date:  2016-03       Impact factor: 1.891

Review 2.  Microbiology and risk factors associated with war-related wound infections in the Middle East.

Authors:  Z T Sahli; A R Bizri; G S Abu-Sittah
Journal:  Epidemiol Infect       Date:  2016-03-02       Impact factor: 4.434

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.